Lumichrome
Based on 2 publication(s) in Google Scholar
Lumichrome, a photodegradation product of Riboflavin, is an endogenous compound in humans. Lumichrome inhibits human lung cancer cell growth and induces apoptosis via a p53-dependent mechanism. Lumichrom is the inhibitor for AKT/β-catenin signaling pathway.
For research use only. We do not sell to patients.
- Purity: 99.84%
- CAS No.: 1086-80-2
- Formula: C12H10N4O2
- Molecular Weight:242.24
-
Storage:
Store at room temperature 3 years.
In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
HY-10108
LY294002 -
HY-W007376
Indole-3-carboxaldehyde -
HY-17394
Cisplatin -
HY-121608
Lumiflavin -
HY-W015224
Methyl 2-(1H-indol-3-yl)acetate -
HY-N3733
Deoxylapachol -
HY-111759
Jaspamycin -
HY-115385R
Lumichrome (Standard) -
HY-100381
Nigericin sodium salt -
HY-15597
Salinomycin -
HY-B0717
Tocofersolan -
HY-101486
LF3
Publications Citing Use of MedChemExpress (MCE) Lumichrome
More
Biological Activity
Description
In Vitro
Lumichrome (0-100 μM, 24 h) exhibits cytotoxicity in cancer cells H292, A549 and H460 (IC50 = 38, 54 and 79 μM, respectively), induces apoptosis in these cells, and inhibits the colony formation[2].
Lumichrome (0-10 μM, 5-28 days) inhibits RANKL-induced osteoclastogenesis and bone resorption through inhibition of NFAT/NF-κB/MAPK/calcium signaling pathways[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:H292, A549 and H460
-
Concentration:0-100 μM
-
Incubation Time:24 h
-
Result:Inhibited cell viability.
-
Cell Line:H292, A549 and H460
-
Concentration:0-50 μM
-
Incubation Time:24 h
-
Result:Increased expression of cleaved PARP, caspase-3/9, increased expression of p53.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:OVX mouse model[3]
-
Dosage:7.5 mg/kg
-
Administration:ip, three times a week for 6 weeks
-
Result:Increased bone mineral density (BMD) and bone volume fraction (BV/TV) in OVX mice, and reduced the osteoclast surface/bone surface (Oc.S/BS) ratio.
Chemical Information
-
CAS No. 1086-80-2
-
Appearance Solid
-
Molecular Weight 242.24
-
Formula C12H10N4O2
-
Color Light yellow to yellow
-
SMILES
O=C(N1)NC2=NC3=CC(C)=C(C)C=C3N=C2C1=O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at room temperature 3 years
In solvent -80°C 2 years -20°C 1 year
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
-
J Ethnopharmacol
Desmodium styracifolium (Osb.) Merr. Extracts alleviate cholestatic liver disease by FXR pathway. [Abstract]2025 Jan 30;337(Pt 3):118972. PMID: 39454708
Solvent & Solubility
In Vitro:
DMSO : 2 mg/mL (8.26 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Bergh VJ, et al. Influence of formulation on photoinactivation of bacteria by lumichrome. Pharmazie. 2015;70(9):574-580. [Content Brief]
[2]. Chantarawong W, et al. Lumichrome Inhibits Human Lung Cancer Cell Growth and Induces Apoptosis via a p53-Dependent Mechanism. Nutr Cancer. 2019;71(8):1390-1402. [Content Brief]
[3]. Liu C, et al., Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signaling. J Cell Physiol. 2018 Nov;233(11):8971-8983. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.1281 mL | 20.6407 mL | 41.2814 mL | 103.2034 mL |
| 5 mM | 0.8256 mL | 4.1281 mL | 8.2563 mL | 20.6407 mL |
Lumichrome Related Classifications
HY-115385 Related Classifications
Powered by Bioz